您的位置:易推广 > 生物试剂/抗体/细胞 > 生物制剂 > 克隆系统 > 上海凯博生物科技有限公司(武汉分公司) > 产品展示 > 抗体 > *新抗体 > Anti-APOB48R载脂蛋白B受体抗体

产品展示

Anti-APOB48R载脂蛋白B受体抗体

点击次数:382发布时间:2012/12/26 2:07:20

Anti-APOB48R载脂蛋白B受体抗体

更新日期:2024/9/5 14:43:27

所 在 地:其它

产品型号:BY-6336R

简单介绍:本公司经销APOB48R,载脂蛋白B受体抗体,克隆类型为polyclonal,宿主来源是Rabbit,APOB48R载脂蛋白B受体抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

优质供应

详细内容

本公司经销APOB48R,载脂蛋白B受体抗体,克隆类型为polyclonal,宿主来源是Rabbit,APOB48R载脂蛋白B受体抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

货号:BY-6336R
英文名称:Anti-APOB48R
中文名称:载脂蛋白B受体抗体
其他名称:apo b-100; APOB; apoB-48R; apoB-100R; apoB100R; Apolipoprotein B-100 receptor; Apolipoprotein B100 receptor; Apolipoprotein B48 receptor.
抗体来源:Rabbit
克隆类型:polyclonal
蛋白分子量:predicted molecular weight: 115kDa
纯化方法:affinity purified by Protein A
交叉反应:hu, mo, rat, dog, Rb
产品介绍:APOB48R is a macrophage receptor that binds to the apolipoprotein B48 of dietary triglyceride (TG) rich lipoproteins. It may provide essential lipids, lipid soluble vitamins and other nutrients to reticuloendothelial cells.Function : Macrophage receptor that binds to the apolipoprotein B48 (APOB) of dietary triglyceride (TG)-rich lipoproteins (TRL) or to a like domain of APOB in hypertriglyceridemic very low density lipoprotein (HTG-VLDL). Binds and internalizes TRL when out of the context of the macrophage. May provide essential lipids to reticuloendothelial cells. Could also be involved in foam cell formation with elevated TRL and remnant lipoprotein (RLP). Mediates the rapid high-affinity uptake of chylomicrons (CM), HTG-VLDL, and trypsinized (tryp) VLDL devoid of APOE in vitro in macrophages.Subunit : Homodimer.Subcellular Location : Cell membrane; Peripheral membrane protein. Note=Binds monocyte-macrophage membrane. Thought to be anchored in the membrane through an interaction with an integral membrane protein.Tissue Specificity : Expressed in peripheral blood leukocytes > bone marrow = spleen > lymph node, and only faintly visible in appendix and thymus. Expressed in the brain, heart, kidney, liver, lung, pancreas, and placenta. Expressed primarily by reticuloendothelial cells: monocytes, macrophages, and endothelial cells. Expressed in atherosclerotic lesion foam cells.Post-translational modifications : There are 2 forms in macrophages, the membrane-binding proteins 200 kDa (MBP 200) and 235 kDa (MBP 235), that can be reduced into a single active ligand-binding species with intermediate mobility (MBP 200R).

联系我们

联系人:王羽

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【未认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:生产商
  • 注册资金:人民币**万

script>
在线咨询

提交